55150-228 : Tigecycline 50 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 55150-228
Labeler: Auromedics Pharma LLC
Product Type: Human Prescription Drug
Drug Name:  Tigecycline
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA206335
Rev. Date: 


NDC Package Codes:

  • 55150-228-10: 10 VIAL IN 1 CARTON (55150‑228‑10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL

Active Ingredients:

  • Tigecycline

Dosage Strength:

  • 50 mg

Pharmaceutical Classes:

  • Tetracycline-class Antibacterial [EPC]
  • Tetracyclines [CS]

Related Products:

Based on records with the same trade name.
  • 0781-3481 Tigecycline 50 mg/10ml Intravenous; Parenteral Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 16729-364 Tigecycline 50 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 60505-6098 Tigecycline 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-960 Tigecycline 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 70121-1647 Tigecycline 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Amneal Biosciences LLC
  • 70594-035 Tigecycline 50 mg Intravenous Injection, Powder, Lyophilized, for Solution by Xellia Pharmaceuticals USA LLC
  • 71288-019 Tigecycline 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55150-228 QR Code

< Prev: 55150-226Next: 55150-230 >

Related Discussions:

tigecycline
details of tegicycline ## More details can be read at: /drug_details.asp?title=Tigecycline&page=1007623&ad=true ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.